Salipro Biotech presents new data in collaboration with AstraZeneca and Thermo Fisher Scientific

Written By Lorena Galan

We are excited to present our latest pre-print that shows how the direct cell extraction of stable and functional membrane proteins enabled the screening of compounds for drug targets via SPR and high-resolution cryo-EM structure determination. The results of this study demonstrate that Salipro DirectMX may accelerate future membrane protein research as well as the development of new therapeutic ligands in a time-efficient and streamlined manner.

Congratulations for a great team work with our collaborators from AstraZeneca and Thermo Fisher Scientific!

Publication Reference:

I.Drulyte, et al. Direct Cell Extraction of Membrane Proteins for Structure- Function Analysis. bioRxiv doi: 10.1101/2022.07.05.498330

Lorena Galan
Previous

New study in Cell uses Salipro technology for investigating autoimmune disease
Next

Out now: Salipro®-Antigens to develop antibodies against GPCRs, ion channels & more